C14H10ClFN2O2S2, monoclinic, P21/n (no. 14), a = 15.070(3) Å, b = 4.9050(10) Å, c = 21.018(4) Å, β = 105.59(3)°, V = 1496.5(5) Å3, Z = 4, Rgt(F) = 0.0667, wRref(F2) = 0.1363, T = 293(2) K
The title compound, C37H34FN3OS2·C2H6OS, was obtained by the Knoevenagel condensation. The thiazolid...
Only two 4-halo-1H-pyrazole crystal structures are known to date (chloro and bromo, the structure of...
The title compound 1-benzhydryl-4-(4-chloro-2-fluoro-benzenesulfonyl)-piperazine was synthesized, an...
C20H12N4Cl2F6O2S, triclinic, P1̄ (no. 2), a = 8.581(3) Å, b = 10.967(4) Å, c = 13.802(5) Å, α = 106....
C16H13Cl2F6N3O3S, monoclinic, P21/n (no. 14), a = 5.8650(10) Å, b = 30.196(5) Å, c = 11.777(2) Å, β ...
C16H14N4Cl2F6O3S, monoclinic, P21/c (no. 14), a = 10.927(3) Å, b = 13.542(3) Å, c = 15.744(4) Å, β =...
In the title compound, C13H10ClFO3S2, the two-ring system is essentially planar, the mean plane of t...
C21H18FN3O3S, monoclinic, P 2(1) (no. 4), a = 11.6665(3) angstrom, b = 5.7483(2) angstrom, c = 14.76...
C11H7ClF3N3OS, monoclinic, C2/c (no. 15), a = 21.9623(8) Å, b = 9.7431(4) Å, c = 16.1379(5) Å, β = 1...
The asymmetric unit of the title compound, C13H10FN3OS2, contains two independent molecules, which d...
C29H25FN6S, triclinic, P1̅, a = 7.5726(8) Å, b = 11.1428(13) Å, c = 16.412(2) Å, α = 91.823(5)°, β =...
C19H14F6N2OS, monclinic, P21/c (no. 14), a = 16.534(2) Å, b = 9.3008(12) Å, c = 12.7681(16) Å, β = 9...
The title compound, C27H17ClFN3O2S, comprises chromonyl (A), thiazolyl (B), pyrazolyl (C), chlorophe...
C10H12ClN3O2S, monoclinic, P121/n1 (no. 14), a = 5.898(1) Å, b = 17.148(3) Å, c = 12.506(2) Å, β = 9...
R factor = 0.037; wR factor = 0.095; data-to-parameter ratio = 18.3. The title compound, C16H12ClFN2...
The title compound, C37H34FN3OS2·C2H6OS, was obtained by the Knoevenagel condensation. The thiazolid...
Only two 4-halo-1H-pyrazole crystal structures are known to date (chloro and bromo, the structure of...
The title compound 1-benzhydryl-4-(4-chloro-2-fluoro-benzenesulfonyl)-piperazine was synthesized, an...
C20H12N4Cl2F6O2S, triclinic, P1̄ (no. 2), a = 8.581(3) Å, b = 10.967(4) Å, c = 13.802(5) Å, α = 106....
C16H13Cl2F6N3O3S, monoclinic, P21/n (no. 14), a = 5.8650(10) Å, b = 30.196(5) Å, c = 11.777(2) Å, β ...
C16H14N4Cl2F6O3S, monoclinic, P21/c (no. 14), a = 10.927(3) Å, b = 13.542(3) Å, c = 15.744(4) Å, β =...
In the title compound, C13H10ClFO3S2, the two-ring system is essentially planar, the mean plane of t...
C21H18FN3O3S, monoclinic, P 2(1) (no. 4), a = 11.6665(3) angstrom, b = 5.7483(2) angstrom, c = 14.76...
C11H7ClF3N3OS, monoclinic, C2/c (no. 15), a = 21.9623(8) Å, b = 9.7431(4) Å, c = 16.1379(5) Å, β = 1...
The asymmetric unit of the title compound, C13H10FN3OS2, contains two independent molecules, which d...
C29H25FN6S, triclinic, P1̅, a = 7.5726(8) Å, b = 11.1428(13) Å, c = 16.412(2) Å, α = 91.823(5)°, β =...
C19H14F6N2OS, monclinic, P21/c (no. 14), a = 16.534(2) Å, b = 9.3008(12) Å, c = 12.7681(16) Å, β = 9...
The title compound, C27H17ClFN3O2S, comprises chromonyl (A), thiazolyl (B), pyrazolyl (C), chlorophe...
C10H12ClN3O2S, monoclinic, P121/n1 (no. 14), a = 5.898(1) Å, b = 17.148(3) Å, c = 12.506(2) Å, β = 9...
R factor = 0.037; wR factor = 0.095; data-to-parameter ratio = 18.3. The title compound, C16H12ClFN2...
The title compound, C37H34FN3OS2·C2H6OS, was obtained by the Knoevenagel condensation. The thiazolid...
Only two 4-halo-1H-pyrazole crystal structures are known to date (chloro and bromo, the structure of...
The title compound 1-benzhydryl-4-(4-chloro-2-fluoro-benzenesulfonyl)-piperazine was synthesized, an...